Abstract
The adverse effects of metals and metalloids on human health are well documented. Blackfoot disease (arsenic), hard-metal lung disease (cobalt and nickel), itai-itai disease (cadmium) and Minamata disease (methylmercury) are recognized clinical entities. There have been numerous studies performed, using different model systems, to determine the effects that metals and metalloids have on biological processes and to relate these effects to clinical syndromes. These studies have contributed greatly to our understanding of the toxic effects that metals and metalloids have on biological processes. Data from these studies have been used to establish regulations and guidelines which resulted in decreasing the release of these elements into the environment and also in limiting human exposure to metal and metalloid compounds. The majority of these studies were performed using acute exposure models in which cells or organisms are exposed to relatively toxic concentrations of metals or metalloids. Acute exposure to toxic concentrations of these environmental pollutants is not likely to occur in today’s environment. Instead most human populations are chronically exposed to concentrations of metal and metalloid ions that are below the threshold levels associated with the development of clinical symptoms. Concerns have been raised about the health risks associated with such exposures (Lave, 1990). In this chapter, information is presented concerning the basic mechanisms by which metals and metalloids are toxic, as well as, chemical and toxicological profiles for several important environmental metal and metalloid pollutants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aberer W. (1991). Topical mercury should be banned-dangerous, outmoded, but still popular. J. Am. Acad. Dermatol. 24:150–51.
Agency for Toxic Substances and Disease Registry U.S. Public Health Service. 1988. The nature and extend of lead poisoning in children in the United States. Department of Health and Human Services, GA.
Alain G., Tousignant J. and Rozenfarb E. (1993). Chronic arsenic toxicity. Int. J. Dermatol. 32:899–901.
Alessio L. and Dell’Orto A. (1988). In Biological Monitoring of Toxic Metals. T.W. Clarkson, L. Friberg, G.F. Nordberg and P.R. Sager (eds.). Rochester Ser. Environ. Toxicity. Plenum Press New York. pp.407–423.
Allenby C.F. and Basketter D.A. (1993). An arm immersion model of compromised skin. II. Influence on minimal eliciting patch test concentrations of nickel. Contact Derm. 20:186–190.
Allenby C.F. and Basketter D.A. (1994). The effect of repeated exposure to low levels of nickel on compromised hand skin of nickel-allergenc subjects. Contact Derm. 30:135–138.
American Conference of Governmental Industrial Hygienists (ACGIH). Threshold Limit Values (TLVs) for Chemical Substances and Physical Agents and Biological Exposure Indices (BEIs). Cincinnati, OH. 1996. American Conference of Governmental Hygienists.
Anderson L., Wingren G. and Axelson O. (1990). Some hygienic observations from the glass industry. Int. Arch. Occup. Environ. Health 62:249–252.
Anderson R.A. (1986). Chromium metabolism and is role in disease processes in man Clin. Physiol. Biochem. 4:31–41.
Anderson R.A. (1994). In Risk Assessment of Essential Elements. W. Mertz, C.O. Abernathy and S.S. Olin (eds.). International Life Sciences Institute Press. Washington DC. pp.187–196.
Aposhian H.V. (1997). Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37:397–419.
Ariza M.E., Bijur G.N. and Williams, M.V. (1998). Lead and mercury mutagenesis: role of H2O2, superoxide dismutase and xanthine oxidase. Environ. Mol. Mutagen. 31:352–361.
Barch D.H. and Iannaccone P.M. (1986). In Essential Nutrients in Carcinogenesis. L.A. Poirier, P.M. Newberne and M.W. Pariza. (eds.). Plenum Press, New York. pp.517–525.
Barltrop D. (1969). Transfer of lead to human fetus. In Barltrop, D., Burland, W.L. eds. Mineral Metabolism in Pediatrics. Davis Co., Philadelphia, PA. pp.135–151.
Barry P.S.I. (1975). A comparison of concentration of lead in human tissue. Br. J. Ind. Med. 32:119–139.
Barry P.S.I. (1981). Concentrations of lead in the tissues of children. Br. J. Ind. Med. 38:61–71.
Bauer J.G. and First H.A. (1982). The toxicity of mercury in dental amalgams. Calif. Dent. Assoc. J. 10:47–61.
Bellinger D., Leviton A., Allred E. and Rabinowitz M. (1994). Pre-and postnatal lead exposure and behavior problems in school-aged children. Environ. Res. 66:12–30.
Bellinger D., Leviton, A. and Sloman J. (1990). Antecedents and correlates of improved cognitive performance in children exposed in utero to low levels of lead. Environ. Health Perspect. 89:5–11.
Bellinger D.C., Leviton A., Waternaux C. Needleman H. and Rabinowitz M. (1987). Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. New Engl. J. Med. 316:1037–1043.
Bellinger D., Needleman H., Bromfield R. and Mintz M. (1984). A follow-up study of the academic attainment and classroom behavior of children with elevated dentine lead levels. Biol. Trace Elem. Res. 6:207–223.
Bensryd I., Rylander L., Hogstedt B., Aprea P., Bratt I., Fahraeus C., Holmen A., Karlsson A., Nilsson A., Svensson B.L., Schutz A., Thomassen Y. and Skerfving S. (1994). Effect of acid precipitation on retention and excretion of elements in man. Sci. Total Environ. 145:81–102
Berg J.M. (1990). Zinc fingers and other metal-binding domains. J. Biol. Chem. 265:6513–6516.
Bjorkman L., Sandborgh-Englund G. and Ekstrand J. (1997). Mercury in saliva and feces after removal of amalgam fillings. Toxicol. Appl. Pharmacol. 144:156–162.
Blazka M.E. and Smith Z.A. (1992). Cadmium and mercury accumulation in rat hepatocytes: interactions with other metal ions. Toxicol. Appl. Pharmacol. 113:118–125.
Bleeker M., Agnew J., Keough J. and Stetson D. (1983). In Neurobehavioral Methods in Occupational Health. P. Gilioh, M. Cassitto. and V. Foa ( eds.) Pergamon Press, Oxford, pp.89–99.
Bourgeois M., Dooms-Goossens A. and Knockaert D. (1986). Mercury intoxication after topical application of a metallic mercury ointment. Dermatologica 172:48–51.
Bradbear R.A., Bain C., Siskind V., Schofield F.D., Webb S., Azelsen E.M., Halliday J.W., Bassett M.L. and Powell L.W. (1985). Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. J. Natl. Cancer Inst. 75:81–84.
Brown L.M., Pottern L.M. and Blot W.J. (1984). Lung cancer in relationship to environmental pollutants emitted from industrial sources. Environ. Res. 34:250–261.
Bull P.C. and Cox D.W. (1994). Wilson’s disease and Menkes disease: New handles on heavy metal transport. Trends Genet. 10:246–252.
Byers R.K. and Lord E.E. (1943). Late effects of lead poisoning in mental development. Am. J. Dis. Child. 66:471–483.
Chavez E., and Holguin J.A. (1988). Mitochondrial calcium release as induced by Hg2+. J. Biol. Chem. 263:3582–3587.
Chelly J., Turner Z., Tonnesen T., Petterson A., Ishikawa B.Y., Tommerup N., Horn N., Monaco A.P. (1993). Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat. Genet. 3:14–19.
Chen G.S., Asai T., Suzuki Y., Nishiokai K. and Nishiyama, S. (1990). A possible pathogenesis for Blackfoot disease-effects of trivalent arsenic (As203) in human umbical vein endothelial cells. J. Dermatol. 17:599–608.
Chen C.J., Chen C.W., Wu M.M. and Kuo T.L. (1992). Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 66:888–892.
Chen C.J., Chuang S.L., Lin T.M. and Wu H.Y. (1985). Malignant neoplasmas among residents of a blackfoot disease-endemic area in Taiwan: high arsenic artesian well water and cancers. Cancer Res. 45:5895–5899.
Chen C.J., Chuang S.L., You, T.M., Lin T.M. and Wu, H.Y. (1986). A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br. J. Cancer 53:399–405.
Chen C.J., Kuo T.L. and Wu H.Y. (1988). Arsenic and cancers. Lancet 1:414–415.
Christoffersson J.O., Schutz A., Skerfving S., Ahlgren L. and Mattson S. (1986). Decrease of skeletal lead levels in man after the end of occupational exposure. Arch. Environ. Health 41:312–318.
Clarkson T.W. (1972). The pharmacology of mercury compounds. Annu. Rev. Pharmacol. 12:375–406.
Clarkson T.W., Friberg L., and Hursh J.B. (1988). In: Biological Monitoring of Toxic Metals. T.W. Clarkson, L. Friberg, G.F. Nordberg, P.R. Sager, (eds). Plenum Press, New York. pp.247–260.
Cohen M.D., Karagacin B., Klein C.B. and Costa M. (1993). Mechanisms of chromium carcinogenicity and toxicity. Crit. Rev.Toxicol. 23:255–281.
Cory-Slechta D.A. (1990). Lead exposure and advanced age: alterations kinetics and biomedical effects. Toxicol. Appl. Pharmacol. 104:67–78.
Cory-Slechta D.A. (1990). Alterations in tissue lead distribution and hematopoietic indices during advanced age. Arch. Toxicol. 64:31–37.
Cory-Slechta D.A. (1995). Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic and glutamatergic neurotransmitter functions. Annu. Rev. Pharmacol. Toxicol. 35:391–415.
Cory-Slechta D.A., Weiss, B. and Cox, C. (1989). Tissue distribution of lead in adults vs. old rats: A pilot study. Toxicology. 59:139–150.
Costa M. (1991). Molecular mechanisms of nickel carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 31:321–337.
Cotran R.S., Kumar V., Robbins S.L. (1989). In Robbin’s Pathological Basis of Disease 5th ed. W.B. Saunders Philadephia PA. pp.861–863.
Cousins R.J. (1994). Metal elements and gene expression. Annu. Rev. Nutr. 14:449–469.
Crichton R.R. and Charloteaux-Waters C. (1987). Iron transport and storage. Eur. J. Biochem. 164:485–506.
Cugell D.W. (1992). Hard metal diseases. Clin. Chest Med. 13:269–279.
Danks D.M. (1993). In Connective Tissue and Its Heritable Disorders. P.M. Royce and B. Steinmann B. (eds.). Wiley-Liss, New York. pp.487–503.
Dave V., Aschner I.J., Fletcher P., Kimelberg H.K. and Aschner M. (1993). Lead increases inositol 1,4,5-triphosphate levels but does not interfere with calcium transients in primary rats astrocytes. Brain Res. 618:9–18.
Davis L.E., Wands J.R. and Weiss S.A. (1974). Central nervous system intoxication from mercurous chloride laxatives, quantitative, histochemical and ultrastructure studies. Arch. Neurol. 30:428–431.
Dawson D.C. and Ballatori N. (1995). Membrane transporters as sites of action and routes of entry of toxic metals. Handbook of Exp. Pharmacol. 115:53–76.
DeBont B., Lauwerys R. and Govaerts H. (1986). Yellow mercuric oxide ointment and mercury intoxication. Eur. J. Pediatr. 145:217–218.
Donaldson W.E. and Knowles S.O. (1993). Is lead toxicosis a reflection of altered fatty acid composition of membranes? Comp. Biochem. Physiol. 104C:377–379.
Environmental Protection Agency (EPA). (1984). Health Assessment Document for Manganese, Final Rep. 1–1 to 10–77. U.S. Environmental Protection Agency, Washington DC.
Environmental Protection Agency and Agency for Toxic Substances and Disease Registry U.S. Public Health Service. (1989). Toxicological Profile For Mercury. Clement Associates. #205-88-0608.
Environmental Protection Agency. (1989). Review of the National Ambient Air Quality Standard for Lead: Exposure analysis, methodology and validation. EPA, Office of Air Quality Office Planning and Standards. EPA-450/2-89-011.
Environmental Protection Agency and Agency for Toxic Substances and Disease Registry U.S. Public Health Service. (1990). Toxicological Profile For Lead. Syracuse Research Corporation #68-C8-0004.
Environmental Protection Agency (EPA). 1997. Computerized Search of the EPA Integrated Risk Information System (IRIS) database.
Enwonwu C.O. (1987). Potential health hazard of use of mercury in dentistry: critical review of the literature. Environ. Res. 422:257–274.
Fergusson D., Fergusson J., Horwood L. and Kinzett N. (1988). A longitudinal study of dentine lead levels, Intelligence, School performance and behaviour. J. Child. Psychol. Psychiatr. 29: 811–824.
Fergusson D., Horwood L. and Lynskey M. (1993). Early dentine lead levels and consequent cognitive and behavioral development. J. Child Psychol. Psychiatr. 34: 827–833.
Fosmire G.J. (1990). Zinc toxicity. Am. J. Clin. Nutr. 51:225–227.
Foulkes E.C. (1990). The concept of critical levels of toxic metals in target tissue. Crit. Rev. Toxicol. 20:327–339.
Fowler A.B. and Weissburg J.B. (1974). Arsine poisoning. N. Engl. J. Med 91:1171–1174.
Fredin B. (1988). Studies on the mercury release from dental amalgam fillings. Swed. J. Biol. Med 3:8–15.
Friberg L., Kjellstrom T. and Nordberg G.F. (1986). In Handbook on the Toxicology of Metals. Vol. 2. 2nd ed. L. Friberg, G. Nordberg and V.B. Voul (eds.). Elsevier, New York. pp.130–184.
Gavis J. and Ferguson J.F. (1972). The cycling of mercury through the environment. Water Res. 6:986–1008.
Gay D.D., Cox R.D. and Reinhardt J.W. (1979). Chewing releases mercury from fillings. Lancet 1:985–986.
Gehardsson L., Chettle D.R., Englyst V., Norberg G.F., Nyhlin H., Scott M.C., Todd A.C. and Vesterberg O. (1992). Kidney effects in long term exposed lead smelter workers. Br. J. Ind. Med. 49:186–192.
Gerber G. M., Maes J., Gilliavod N. and Casale G. (1978). Brain biochemistry of infant mice and rats exposed to lead. Toxicol. Lett. 2:51–63.
Goering P.L., Galloway W.D., Clarkson T.W., Lorscheider F.L., Berlin M. and Rowland A.S. (1992). Toxicity assessment of mercury vapor from dental amalgams. Fund. Appl. Toxicol. 19:319–329.
Gonick H.C., Ding Y., Bondy S.C., Zhenmin N. and Vaziri D. (1997). Lead-induced hypertension. Interplay of nitric oxide and reactive oxygen species. Hypertension 30:1487–1492.
Graeme K.A. and Pollack C.V. (1998). Heavy metal toxicity. Arsenic and Mercury. J. Emerg. Med. 16:45–56.
Grandjean P., Nielsen G.D., and Anderson O. (1989). In Nickel and the Skin: Immunology and Toxicology. H.I. Maibach and T. Menne (eds.). CRC Press Boca Raton FL. pp.9–34.
Habermann E., Crowell, K. and Janicki P. (1983). Lead and other metals can substitute for calcium in calmodulin. Arch. Toxicol. 54:61–70.
Haenninem M., Mantere P., Hernberg S., Seppalainen A. and Koch B. (1979). Subjective symptoms in low-level exposure to lead. Neurotoxicology 1:333–347.
Hanson M. and Pleva J. (1991). The dental amalgam issue. A review. Experimentia 47:9–22.
Harada H. (1978). Congenital Munamata disease: Intrauterine methylmercury poisoning. Teratology 18:285–288.
Hayes R.B. (1988). Review of occupational epidemiology of chromium chemicals and respiratory cancer. Sci. Total Environ. 71:331–339.
Hertz-Picciotto I. and Croft J. (1993). Review of the relation between blood lead and blood pressure. Epidemiological Rev. 15:352–373.
Hertz-Picciotto I., Smith A.H., Holzman D., Lipsett M. and Alexeeff G. (1992). Syngerism between occupational arsenic exposure and smoking in the induction of lung cancer. Epidemiology 3:23–31.
Hinkel P.M., Kinsella P.A. and Osterhoudt K.C. (1987). Cadmium uptake and toxicity voltage sensitive calcium channels. J. Biol. Chem. 262:16333–16337.
Hinkel P. and Osborne M. (1994). Cadmium toxicity in rat phechromocytoma cells: studies on the mechanism of uptake. Toxicol. Appl. Pharmacol. 124:91–98.
Hogstedt C., Hane M., Agrell A. and Bodin L. (1983). Neuropsycological test results and symptoms among workers with well defined long-term exposure to lead. Br. J. Ind. Med. 40:99–105.
Horiguchi K., Horiguchi S. and Suekane M. (1959). Studies on industrial lead poisoning. I: absorption, transportation, deposition and excretion of lead. Osaka City Med. J. 5:41–70.
Hsing A.W., McLaughlin J.K., Olsen J.H., Mellemkjar L., Wacholder S. and Fraumeni J.F. (1995). Cancer risk following primary hemochromatosis: A population-based cohort study in Denmark. Int. J. Cancer 60:160–162.
Hu H., Aro A., Payton M., Korrick S., Sparrow D., Weiss S.T. and Rotnitzky A. (1996). The relationship of bone and blood lead to hypertension. The normative aging study. J. Am. Med. Assoc. 275:1171–1177.
IARC. (1990). In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 49. International Agency for Research on Cancer, Lyon.
IARC. (1993). In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 58. International Agency for Research on Cancer, Lyon. pp.119–237.
Jaffe K.M., Shurtleff D.B. and Robertson, W.O. (1983). Survival after acute mercury vapor poisoning, role of intensive supportive care. Am. J. Dis. Child. 137:749–751.
Jensen A.A. and Tuchsen F. (1990). Cobalt exposure and cancer risk. Crit. Rev. Toxicol. 20:427–437.
Johnson D.L. and Braman R.S. (1974). Distribution of atmospheric mercury species near the ground. Environ. Sci. Technol. 8:1003–9.
Jones P., Kortenkamp A., O’Brian P., Wang G. and Yang G. (1990). Evidence for the generation of hydroxyl radicals from chromium (V) intermediate isolated from the reaction of Chromate with glutathione. Arch. Biochem. Biophys. 277:342–350.
Kahn M.F., Ohno Y. and Takanaka A. (1992). Effects of tetrakis-μ-3,5-diisopropylsalicylatodiaquodicopper (II) on the status of reduced glutathione in freshly-isolated hepatocytes. Arch. Toxicol. 66:587–591.
Kasprzak K.S. (1991). Nickel (II) mediated oxidative DNA base damage in renal and hepatic chromatin of pregnant rats and their fetuses. Chem. Res.Toxicol. 4:604–615.
Kazantzis G. (1987). In Advances in Modern Toxicology. Vol XI. L. Fishbein, A. Furst and M.A. Mehlman (eds.). Princeton Scientific Princeton NJ. pp. 127–143.
Khalil-Manesh F. Gonick H.C. and Cohen A.H. (1992). Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int. 41: 1192–1203.
Khalil-Manesh F., Gonick H.C. and Cohen A.H. (1993). Experimental model of lead nephropaphy. III. Continuous low-level lead administration. Arch. Environ. Health 48: 271–278.
Kim R., Rotnitzky A., Sparrow D., Weiss S.W., Wager C. and Hu H. (1996). A longitudinal study of low-level lead exposure and impairment of renal function. The normative aging study. J. Am. Med. Assoc. 275:1177–1181.
Kiss T. and Osipenko O.N. (1994). Toxic effects of heavy metals on ionic channels. Pharmacological Rev. 46:245–267.
Klein, C.B., Frenkel K. and Costa M. (1991). The role of oxidative processes in metal carcinogenesis. Chem. Res. Toxicol. 4:592–604.
Knekt P., Reunanen H., Takkunen H., Aroma A., Heliovaara M. and Hakulinen T. (1994). Body iron stores and risk of cancer. Int J. Cancer 56:379–382.
Kusaka Y., Yokoyama K., Sera Y., Yamamota S., Stone S., Kyono H., Shirakawa T. and Goto S. (1986). Respiratory diseases in hard metal workers: an occupational hygiene study in a factory. Br. J. Ind. Med. 43:474–485.
Langan D.C. Fan P.L. and Hoos A.A. (1987). The use of mercury in dentistry: a critical review. J. Am. Dent. Assoc. 115:867–880.
Langard S. (1990). One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 17:189–215
Laterra J., Bressler J., Indurti R.R. and Belloni-Olivi, L. (1992). Inhibition of astroglia-induced endothelial differentiation by inorganic lead: A role for protein kinase C. Proc. Natl. Acad. Sci. U.S.A. 89:10748–10752.
Lave L.B. and Ennever F.K. (1990). Toxic substances control in the 1990s: Are we poisoning ourselves with low-level exposures? Annu. Rev. Public Health 11:69–87.
Lawton L.J. and Donaldson W. E. (1991). Lead-induced tissue fatty acid alterations and lipid peroxidation. Biol. Trace Elem. Res. 28:83–97.
Linder M.C., Wooten L., Cerveza P., Cotton, S., Schulze R. and Lomeli N. (1998). Copper transport. Am. J. Clin. Nutrition 67:965S–971S.
Lison D. (1995). Physicochemical mechanisms of the interaction between cobalt metal and carbide particles to generate toxic activated oxygen species. Chem. Res. Toxicol. 8:600–606.
Lockitch G. (1993). Perspectives on lead toxicity. Clin. Biochem. 26:371–381.
Long G.J., Rosen J.F. and Schanne F.A.X. (1994). Lead activation of Protein Kinase C from rat brain. Determination of free calcium, lead and zinc by 19F NMR. J. Biol. Chem. 269:834–837.
Lorscheider F.L. and Vimy M.J. (1985). Intra-oral air mercury released from dental amalgam. J. Dent. Res 64:1069–1071.
Lorscheider F.L. and Vimy M.J. (1993). Evaluation of the safety issue of mercury release from dental fillings. FASEB J. 7:1432–1433.
Lorscheider F.L., Vimy M.J., and Summers A.O. (1995). Mercury exposure from “silver” tooth fillings: emerging evidence questions a traditional dental paradigm. FASEB J. 9:504–08.
Mackert, J.R. (1987). Factors affecting estimation of dental amalgam mercury exposure from measurements of mercury vapor levels in intra-oral and expired air. J. Dent. Res. 66:1775–1780.
Magos L., Halbach S., and Clarkson T.W. (1977). Role of catalase in the oxidation of mercury vapor. Biochem. Pharmacol. 27:1373–1377.
Malmstrom C., Hansson M. and Nylander M. (1992). Amalgam-derived mercury in feces. J. Trace Elem. Exp. Med. 5:122.
Marco-Feced C. In Encyclopaedia of Occupational Health and Safety. 3rd edition. Vol 2. L. Parmeggiani L (ed.). International Labor Office, Geneva pp. 1281–1282.
Markovac J. and Goldstein G.W. (1988). Picomolar concentrations of lead stimulate brain protein kinase C. Nature 334:71–73.
Mazunder D.N., DasGupta J., Santra A., Pal A., Ghose A. and Sarkar A. (1998). Chronic arsenic toxicity in West Bengal. The worst calamity in the world. J. Ind. Med. Ass. 96:4–7.
McCracken J. (1987). Lead intoxication psychosis in an adolescent. J. Am. Acad. Child. Adol. Psychiatr. 26:274–276.
McFarland R. and Reigel H. (1978). Chronic mercury poisoning from a single brief exposure. J. Occup. Med. 20: 534–534.
McMichel A.J., Baghurst P.A. Wigg N., Vimpani G.V., Robertson E.F. and R.J. Roberts. (1988). Port Pirie cohort study: environmental exposure to lead and children’s abilities at the age of four years. New Engl. J. Med. 319:468–475.
Menne T. (1994). Quantitative aspects of nickel dermatitis: sensitizating and eliciting threshold concentrations. Contact Derm. 29:180–184.
Mercer J.F., Livingston J., Hall B., Payner J.A., Begy C., Chandrasekharappa S., Lockhart P., Grimes A., Bhave M., Siemieniak D. and Glover T.W. (1993). Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat. Genet. 3:20–25.
Minnema D.J., Michelson I.A. and Cooper G.P. (1988). Calcium effux and neurotransmitter release from rat hippocampal synaptosomes exposed to lead. Toxicol. Appl. Pharmacol. 92:351–357.
Mossman B.T., Bignon J., Corn M., Seaton A. and Gee J.B.L. (1990). Asbestos: scientific developments and implications for public policy. Science 247:294–301.
Mudassar S., Andrabi K.I., Khullar M., Ganguly N.K., and Walia B.N.S. (1992). Effect of exogenous copper on lipid peroxidation in rat hepatocytes. Possible involvement of protein kinase C. J. Pharm. Pharmacol. 44:609–611.
Murakami K., Feng G. and Chen S.G. (1993). Inhibition of brain protein kinase C subtypes by lead. J. Pharmacol. Exp. Thera. 264:757–761.
Nakagawa H., Tabata M., Morikawa Y., Senma M., Kitagawa Y., Kawano S. and Kido T. (1990). High mortality and shortened life-span in patients with itai-itai disease and subjects with suspected disease. Arch. Environ. Health 45:283–287.
Nakatani T., Spolter L. and Kobayasni K. (1994). Redox state in liver mitochondria in acute copper sulfate poisoning. Life Sci. 54:967–974.
Nathanson M.H., Mariwalla K., Ballatori, N. and Boyer J.L. (1995). Effects of Hg2+ on cytosolic calcium in isolated skate hepatocytes. Cell Calcium 18:429–439.
National Institute for Occupational Safety and Health (NIOSH): Pocket Guide to Chemical Hazards. NIOSH 94–116. Washington D.C. U.S. Department of Health and Human Services. 1994.
Needleman H.L., and Bellinger D. (1991). The health effects of low level exposure to lead. Ann. Rev. Publ. Health 12:111–140.
Needleman H.L., Schell A., Bellinger D., Leviton A. and Allred, E.N. (1990). The long-term effects of exposure to low doses of lead in childhood. N. Engl. J. Med. 322:83–88.
Nelson R.G., Davis F.G., Sutter E., Sobin L.H., Kikendall J.W. and Bowen P. (1994). Body iron stores and risk of colonic neoplasia. J. Natl. Cancer Inst. 86:455–460.
Nelson R.L. (1990). In Metals in Biology and Medicine, Vol 1. P. Collery, L.A. Poirier M. Manfait and J.C. Etiene (eds.). John Libbey Eurotext, Parris. pp.35–42.
Nelson R.L. (1992). Dietary iron and colorectal cancer risk. Free Radical Biol. Med. 12:161–168.
Nethercott J., Paustenbach D., Adams R., Fowler J., Marks J., Morton C., Taylor J., Horowitz S. and Finley B. (1994). A study of chromium induced allergic contact dermatitis with 54 volunteers amplications for environmental risk assessment. Occup. Environ. Med. 51:371–380.
Ngim C.H. and Devathason G. (1989). Epidemiologic study on the association between body burden mercury level and idiopathic Parkinson’s disease. Neuroepidemiology 8:128–141.
Niedereau C. and Strohmyer G. (1985). Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. N. Engl. J. Med. 313:1256–1262.
Nordberg G.F. and Nordberg M. (1988). InBiological Monitoring of Toxic Metals. T.W. Clarkson, L. Friberg, G.F. Norberg and P.R. Sager (eds.) Plenum Press, New York NY. pp.151–167.
Nylander M., Friberg L. and Lind B. (1987). Mercury exposure in the human brain and kidneys in relation to exposure from dental amalgam fillings. Swed. Dent. J. 11: 179–187.
Oberdorster G. (1986). Airborne cadmium and carcinogenesis of the respiratory tract. Scand. J. Work Environ. Health 12:523–537.
Oberdoester G. and Cherian G. (1988). In Biological Monitoring of Toxic Metals. T.W. Clarkson, L. Friberg, G.F. Nordberg and Z.P.R. Saget (eds.). Rochester Ser. Environ. Toxicity. Plenum Press New York. pp.283–301.
O’Flaherty E.J., Hammond P.B. and Lerner S.I. (1982). Dependence of apparent blood lead half-life on the length of previous lead exposure in humans. Fundamentals Appl. Toxicol. 2: 49–54.
Ozawa T. and Hanaki A. (1990). Spin-trapping studies on the reactions of Cr (III) with hydrogen peroxide in the presence of biological reductants. Is Cr (III) nontoxic? Biochem Int. 22:343–352.
Parkinson D., Ryan C., Bromet E. and Connell M. (1986). A psychiatric epidemiologic study of occupational lead exposure. Am. J. Epidemiol. 123:261–269.
Pasternak G., Becker C., Lash A., Bowler R., Estrin W. and Law D. (1989). Cross-sectional neurotoxicology study of lead-exposed cohort. Clin. Toxicol. 27:37–51.
Patterson J.E., Weissberg B. and Dennison P.J. (1985). Mercury in human breath from dental amalgams. Bull. Environ. Contam. Toxicol. 34:459–468.
Paustenbach D.J., Meyer D.M., Sheehan P.J. and Lau V. (1991). An assessment and quantitative uncertainty analysis of the health risks to workers exposed to chromium contaminated soils. Toxicol. Ind. Health 7:159–196.
Payton M., Hu H., Sparrow D. and Weiss S.T. (1994). Low-level lead exposure and renal function in the normative aging study. Am. J. Epidemiol. 140:821–829.
Peereboom-Stegeman, J.H. (1987). Toxic trace elements and reproduction. Toxicol. Environ. Chem. 15:273–292.
Pendergrass J.C., Haley B.E., Vimy M.J., Winfield S.A. and Lorscheider F.L. (1997). Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: similarity to a molecular lesion in Alzheimer diseased brain. Neurotoxicol. 18:315–324.
Peters G.R., McCurdy R.F. and Hindmarsh J.T. (1996). Environmental aspects of arsenic toxicity, Crit. Res. Clin. Lab. Sci. 33:457–493.
Pirkle J.L., Schwartz J., Landis J.R. and Harlan W.R. (1985). The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am. J. Epidemiol. 121:246–258.
Rabinowitz M.B., Wetherill G.W. and Kopple J.D. (1976). Kinetic analysis of lead metabolism in healthy humans. J. Clin. Invest. 58: 260–270.
Ramm G.A., Powell L.W. and Halliday J.W. (1994). Pathways of intracellular trafficking and release of ferritin by the liver in vivo: The effect of chloroquine and cytochalastin D. Hepatol. 19:504–513.
Ramstoeck E.R., Hoekstra W.G. and Ganther H.E. (1980). Trialkyllead metabolism and lipid peroxidation in vivo in vitamin E-and selenium deficient rats as measured by ethane production. Toxicol. Appl. Pharmacol. 54:251–257.
Reinhardt J.W. (1988). Risk assessment of mercury exposure from dental amalgams. J. Public Health Dentistry. 48:172–177.
Roels H., Lauwerys R., and Buchet J.P. (1982). Comparison of renal function and psychomotor performance in workers exposed to elemental mercury. Int. Arch. Occup. Environ. Health 50: 7–93.
Rhodes D. and Klug A. (1993). Zinc fingers. Sci. Am. 2:56–65.
Romaguera C. Grimait F. and Vilaplana J. (1988). Contact dermatitis from nickel: an investigation of its sources. Contact Derm. 19:52–57.
Sandstead H.H. (1995). Requirements and toxicity of essential trace elements illustrated by zinc and copper. Am. J. Clin. Nutr. 6:621S-624S.
Santucci B., Ferrari P.V., Cristaudo A., Cannistraci C., and Picardo M. (1989). Nickel dermatitis from cheap ear rings. Contact Derm. 21:245–248.
Saric, M. (1991). In Encyclopaedia of Occupational Health and Safety. 3rd edition. Vol 2. L. Parmeggiani (ed.). International Labor Office, Geneva. pp. 1279–1280.
Schafer T., Benters J. and Beyersmann D. (1994). In Metal Ions in Biology and Medicine. Vol 3. P. Collery, L.A. Poirier, N.A. Littlefield and J.C. Etienne (eds.) John Libbey Eurotext Montrouge, France. pp.137–152.
Scheuhammer A.M. and Cherian M.G. (1985). Binding of manganese in human and rat plasma. Biochem. Biophys. ACTA 840:163–169.
Schottenfeld R. and Cullen M. (1984). Organic effective illness associated with lead intoxication. Am. J. Psychiatr. 141:1423–26.
Schubert H., Berova N., Czernielewski A., Hegyi E., Jirase K.L., Kohanaka V, Korossy S., Michailov P., Webenfuhrer L. and Prater E. (1987). Epidemiology of nickel allergy. Contact Derm. 16:122–128.
Schutz A., Skerfving S., Christofferson J.O., Ahlgren L. and Mattson S. (1987). Lead in vertebral bone biopsies from active and retired lead workers. Arch. Environ. Health 42:340–346.
Schwartz J. (1995). Lead, blood pressure and cardiovascular disease in men. Arch. Environ. Health 50:31–37.
Selby J.V. and Friedman G.D. (1988). Epidemiological evidence of an association between body iron stores and risk of cancer. Int. J. Cancer 41:677–682.
Seligman P.A. Klausner R.D. and Huebers H.A. (1987). In The Molecular Basis of Blood Diseases. G. Stamatoyannopoulos, A.W. Nienhuis, P. Leder and P.W. Majerus (eds.). W.B. Saunders Philadelphia PA. pp.219–244.
Shaikh Z. (1991). In Metallothionein in Biology and Medicine. C.D. Klaassen and K.T. Suzuki (eds.). CRC Press. Boca Raton FL. pp.383–391.
Sheehan P.J., Meyer D.M., Sauer M.M. and Paustenbach D.J. (1991). Assessment of human health risks posed by exposure to chromium-contaminated soils. J. Toxicol. Environ. Health 32:161–201.
Shi X. and Dalal N.S. (1989). Chromium (V) and hydroxyl radical formation during the glutathione reductase-catalyzed reduction of chromium (VI). Biochem. Biophys. Res. Commun. 163:627–634.
Shi X. and Dalal N.S. (1990). On the hydroxyl radical formation in the reaction between hydrogen peroxide and biologically generated chromium (V) species. Arch. Biochem. Biophys. 277:342–350.
Shi X., Dalal N.S. and Kasprzak K.S. (1993). Generation of free radicals from hydrogen peroxide and lipid hydroperoxides in the presence of Cr (III). Arch. Biochem. Biophys. 302:294–299.
Shibuya I. and Douglas W.W. (1992). Calcium channels in rat melanotrophs are permeable to manganese, cobalt, cadmium and lanthanum but not to nickel: evidence provided by fluorescence changes in Fura-2-loaded cells. Endocrinology 131:1936–1941.
Silva P.A., Hughes P., Williams S. and Faed, J.M. (1988). Blood lead, intelligence, reading attainment and behaviour in eleven year old children in Dunedin, New Zealand. J. Child Psychol. Psychiatr. 29:43–52.
Simons T.J.B. and Pocock G. (1987). Lead enters adrenal medullary cells through calcium channels. J. Neurochem. 48: 383–389.
Smith A.H., Hopenhayn-Rich C., Bates M.N., Goeden H.N., Hertz-Picciotto I.H., Duggan I., Wood R., Kosnett M. and Smith M.T. (1992). Cancer risks from arsenic in drinking water. Environ. Health. Perspect. 97:259–267.
Smith P.J., Langolf G.D., and Goldberg J. (1983). Effects of occupational exposure to elemental mercury on short term memory. Br. J. Ind. Med. 40: 413–419.
Snapp, K.R., Svare, C.W., and Petterson, L.C. (1986). Contribution of dental amalgams to blood mercury levels. J. Dent. Res. 65:1276.
Snodgrass W., Sullivan J.B. and Rumack B.H. (1981). Mercury poisoning from home gold ore processing. Use of penicillamine and dimercaprol. J. Am. Med. Assoc. 246:1929–1931.
Staessen J.A., Lauwerys R.R., Buchet J.P., Bulpitt C.J., Rondia D., Vanrenterghem Y. and Amery A. (1992). Impairment of renal function with increasing blood lead concentrations in the general population. New. Engl. J. Med. 327:151–156.
Standeven A.M. and Wetterhan K.E. (1989). Chromium (VI) toxicity: uptake, reduction and DNA damage. J. Am. Coll. Toxicol. 8:1275–1283.
Stayner L., Smith R., Thun M., Schorr T. and Lernen R. (1992). A dose-response analysis and quantitative assessment of lung cancer risk and occupational cadmium exposure. Ann. Epidemiol. 2:177–194.
Steinhoff D. and Mohr U. (1991). On the question of a carcinogenic action of cobalt-containing compounds. Exp. Pathol. 41:169–174.
Stevens R.G., Beasley R.P. and Blumberg B.S. (1986). Iron-binding proteins and risk of cancer in Taiwan. J. Natl. Cancer Inst. 76:605–610.
Stevens R.G., Graubard B.I., Micozzi M.S., Neriishi K. and Blumberg B.S. (1994). Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int. J. Cancer 56:364–369.
Stevens, R.G., Jones D.Y., Micozzi M.S. and Taylor P.R. (1988). Body iron stores and the risk of cancer. N. Engl. J. Med. 319:1047–1052.
Stock A. (1926). Die gefahrlichkeit des quecksilberdampfes. Z. Angew. Chem. 39:461–466.
Stohs S.J. and Bagchi D. (1995). Oxidative mechanisms in the toxicity of metal ions. Free Radical Biol. Med. 18:321–336.
Stromberg U., Schutz A. and Skerfving S. (1995). Substantial decreases of blood lead in Swedish children, 1974–1994, associated with petrol lead. Occup. Environ. Med. 52:764–769.
Suarez N. and Eriksson H. (1993). Receptor-mediated endocytosis of a manganese complex of transferrin into neuroblastoma (SHSY5Y) cells in culture. J. Neurochem. 61:127–131.
Sugiyama M. (1992). Role of physiological antioxidants in chromium (VI)-induced cellular injury. Free Radical Biol. Med. 12:397–407.
Summers A.O. (1978). Microbial transformations of metals. Annu. Rev. Microbiol. 32:637–72.
Sunderman F.W. Jr., Hopfer S.M., Sweeny K.C., Marcus A.H., Most B.M. and Creason J. (1989). Nickel absorption and kinetics in human volunteers. Proc. Soc. Exp. Biol. Med. 191:5–11
Tell I., Somervaille L.J., Nilsson U., Bensryd I., Schutz A., Chetile D.R., Scott M.C. and Skerfving S. (1992). Chelated lead and bone lead. Scand. J. Work Environ. Health 18:113–119.
Thacker S.B., Hoffman D.A., Smith J., Steinberg K., and Zack M. (1992). Effects of low-level lead body burdens on the mental development of children: limitations of meta-analysis in a review of longitudinal data. Arch. Environ. Health. 47:336–346.
Thonson G., Raab G., Hepburn W., Hunter R., Fulton M. and Laxen D. (1989). Blood-lead levels and childrens’ behaviour: Results from the Edinburgh lead study. J. Child Psychol. Psychiatr. 30: 515–528.
Tossavainen A., Nurminen M., Mutanen P. and Tola S. (1980). Application of mathematical modeling for assessing the biological half-times of chromium and nickel in field studies. Br. J. Ind. Med. 37:285–291.
Toyokuni S. (1996). Iron-induced carcinogenesis: The role of redox regulation. Free Radical Biol. Med. 20:553–566.
Tseng, W.P. (1989) Blackfoot disease in Taiwan: a 30 year follow-up study. Angiology 40:547–558.
Vallee B.L. and Ulmer D.D. (1972). Biochemical effects of mercury, cadmium and lead. Annu. Rev. Biochem. 41:91–145.
Vimy M.J., and Lorscheider F.L. 1990. Dental amalgam mercury daily dose estimated from intra-oral vapor measurements: a predictor of mercury accumulation in human tissues. J. Trace Elem. Exp. Med. 3:111–123.
Vulpe C., Levinson B., Whitney S., Packman S. and Gitschier J. (1993). Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat. Genet. 3:7–13.
Waalkes MP, Rehm S, Sass B, and Ward JM. (1992). In Cadmium in the Human Environment: Toxicity and Carcinogenicity. G.F. Nordberg, L. Alessio and R.F.M. Herber (eds.). IARC Sci Pub. International Agency for Research on Cancer Lyon France. pp.401–417.
Wang X. (1993). Cobalt (II) and nickel (II) ions as promoters of free radicals in vivo: detected directly using electron spin resonance spectrophotometry in circulating blood in rats. Arch. Biochem. Biophys. 306:402–406.
Weinberg J.M., Harding P.G. and Humes, H.D. (1982a). Mitochondrial bioenergetics during of mercuric chloride-induced renal injury. I. Direct effects of in vitro mercuric chloride on renal cortical mitochondrial function. J. Biol. Chem. 257:60–67.
Weinberg J.M., Harding P.G. and Humes H.D. (1982b). Mitochondrial bioenergetics during of mercuric chloride-induced renal injury. II. Functional alterations of renal cortical mitochondria isolated after mercuric chloride treatment. J. Biol. Chem. 257:68–74.
Weiss S.T., Munoz A., Stein A., Sparrow D. and Speizer F.E. (1986). The relationship of blood lead to blood pressure in a longitudinal study of working men. Am. J. Epidemiol. 123:800–808.
Wenstrup D., Ehmann W.D. and Markesbery W.R. (1990). Trace element imbalances in isolated subcellular fractions of Alzheimer’s disease brains. Brain Res. 533:125–131.
Willems M.I., de Schepper G.G., Wibowo A.A.E., Immel H.R., Dietrich A.J.J., and Zielhuis R.L. (1982). Absence of an effect of lead acetate on sperm morphology, sister chromatid exchange or on micronuclei formation in rabbits. Arch. Toxicol. 50:149–157.
Wingren G. and Axelson O. (1987). Mortality in the Swedish glasswork industry. Scand. J. Work Environ. Health 13:412–416.
Wright T.L., Fitz J.G. and Weisimger R.A. (1988). Non transferrin-bound iron uptake by rat liver. Role of membrane potential release. J. Biol. Chem. 263:1842–1847.
Yule W. (1992). Review: Neurotoxicity of lead. Child: care, health and development. 18:321–337.
Yule W., Urbanowicz M., Lansdown R. and Millar I. (1984). Teachers’ ratings of children behavior in relation to blood lead levels. Br. J. Dev. Psychol. 2:295–305.
Zelikoff J.T., Li J.H., Hartwig A., Wang X.W., Costa M. and Rossman T.G. (1988). Genetic toxicology of lead compounds. Carcinogenesis 9:1727–1732.
Zeng J., Heuchel R., Schaffner W. and Kagi J.H.R. (1991a). Thionein (aprometallothionein) can modulate DNA binding and transcription activation by zinc finger containing factor Spl. FEBS Lett 279:310–312.
Zeng J., Vallee B. and Kagi J.H.R. (1991b). Zinc transfer from transcription factor IIIA fingers to thionein clusters. Proc. Natl. Acad. Sci. USA. 88:9984–9988.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ariza, M.E., Bijur, G.N., Williams, M.V. (1999). Toxicological Profiles. In: Environmental Metal Pollutants, Reactive Oxygen Intermediaries and Genotoxicity. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5153-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5153-9_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7346-9
Online ISBN: 978-1-4615-5153-9
eBook Packages: Springer Book Archive